New drug shows promise for controlling stubborn high blood fats
NCT ID NCT05413135
First seen Nov 01, 2025 · Last updated May 17, 2026 · Updated 26 times
Summary
This study looked at the long-term safety of a drug called ARO-APOC3 in 418 adults with dyslipidemia (abnormal levels of fats in the blood). Participants who completed a previous 12-month study received the drug every 3 to 6 months. The main goal was to track side effects, and researchers also measured changes in triglycerides and other blood fats over time.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DYSLIPIDEMIAS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Clincal Research Site 4
Boca Raton, Florida, 33434, United States
-
Clinical Research Site 1
Beverly Hills, California, 90211, United States
-
Clinical Research Site 10
Pembroke Pines, Florida, 33024, United States
-
Clinical Research Site 11
Port Orange, Florida, 32127, United States
-
Clinical Research Site 12
Dunwoody, Georgia, 30338, United States
-
Clinical Research Site 13
Minneapolis, Minnesota, 55455, United States
-
Clinical Research Site 14
Tupelo, Mississippi, 38801, United States
-
Clinical Research Site 15
Omaha, Nebraska, 68114, United States
-
Clinical Research Site 16
Las Vegas, Nevada, 89121, United States
-
Clinical Research Site 17
Long Island City, New York, 11106, United States
-
Clinical Research Site 18
New Windsor, New York, 12553, United States
-
Clinical Research Site 19
New York, New York, 10029, United States
-
Clinical Research Site 2
Northridge, California, 91325, United States
-
Clinical Research Site 20
Morehead City, North Carolina, 28557, United States
-
Clinical Research Site 21
Fargo, North Dakota, 58104, United States
-
Clinical Research Site 22
Marion, Ohio, 43302, United States
-
Clinical Research Site 23
Maumee, Ohio, 43537, United States
-
Clinical Research Site 24
Oklahoma City, Oklahoma, 73135, United States
-
Clinical Research Site 25
Greenville, South Carolina, 29607, United States
-
Clinical Research Site 26
Chattanooga, Tennessee, 37421, United States
-
Clinical Research Site 27
Houston, Texas, 77030, United States
-
Clinical Research Site 28
Houston, Texas, 77099, United States
-
Clinical Research Site 29
Houston, Texas, 77002, United States
-
Clinical Research Site 3
Palm Springs, California, 92292, United States
-
Clinical Research Site 30
San Antonio, Texas, 78249, United States
-
Clinical Research Site 31
Manassas, Virginia, 20110, United States
-
Clinical Research Site 32
Camperdown, New South Wales, 2050, Australia
-
Clinical Research Site 33
Milton, Queensland, 4068, Australia
-
Clinical Research Site 34
Sippy Downs, Queensland, 4556, Australia
-
Clinical Research Site 35
Adelaide, South Australia, 5000, Australia
-
Clinical Research Site 36
Clayton, Victoria, 3168, Australia
-
Clinical Research Site 37
Joondalup, Washington, 6027, Australia
-
Clinical Research Site 38
Nedlands, Washington, 6009, Australia
-
Clinical Research Site 39
Concord, Ontario, L4K4M2, Canada
-
Clinical Research Site 40
London, Ontario, N6A 5A5, Canada
-
Clinical Research Site 41
Chicoutimi, Quebec, G7H 7K9, Canada
-
Clinical Research Site 43
Montreal, Quebec, H2W 1R7, Canada
-
Clinical Research Site 44
Québec, Quebec, G1G 3Z4, Canada
-
Clinical Research Site 46
Balatonfüred, H-8230, Hungary
-
Clinical Research Site 47
Békéscsaba, 5600, Hungary
-
Clinical Research Site 48
Debrecen, 4032, Hungary
-
Clinical Research Site 49
Gyöngyös, 3200, Hungary
-
Clinical Research Site 5
Fort Lauderdale, Florida, 33308, United States
-
Clinical Research Site 50
Komárom, H-2900, Hungary
-
Clinical Research Site 51
Nyíregyháza, 4400, Hungary
-
Clinical Research Site 53
Amsterdam, 1105 AZ, Netherlands
-
Clinical Research Site 54
Sneek, 8601 ZR, Netherlands
-
Clinical Research Site 55
Zwijndrecht, 3331LZ, Netherlands
-
Clinical Research Site 56
Christchurch, 8011, New Zealand
-
Clinical Research Site 57
Christchurch, 8013, New Zealand
-
Clinical Research Site 58
Papatoetoe, Aukland, 2025, New Zealand
-
Clinical Research Site 59
Bydgoszcz, 85-605, Poland
-
Clinical Research Site 6
Miami, Florida, 33173, United States
-
Clinical Research Site 60
Oświęcim, 32-600, Poland
-
Clinical Research Site 61
Poznan, 61-655, Poland
-
Clinical Research Site 62
Rzeszów, 35-055, Poland
-
Clinical Research Site 63
Lodz, 94 046, Poland
-
Clinical Research Site 64
Lodz, 93-338, Poland
-
Clinical Research Site 8
Miami, Florida, 33155, United States
-
Clinical Research Site 9
Miami Springs, Florida, 33166, United States
Conditions
Explore the condition pages connected to this study.